News in Research
Archives
2006 | 2005 | 2004 | 2003 |2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996
2006
November 22, 2006
Sex Hormone Trial in Women with MS Launched
November
1, 2006
Abnormal liver test results found in people with multiple sclerosis
in placebo arms of clinical trials
October 31, 2006
Canadian
study finds MS increasing among women
October 4, 2006
Health Canada approves Tysabri for treatment of relapsing MS
September 29, 2006
Vitamin
B3 protects nerve tissue from further damage in mice with MS-like
disease
September 6, 2006
Transmission of MS to children: Study finds men transmit MS more often to their children than do women
August
22, 2006
Clinical trial of oral therapy: Fingolimod study will involve 1,250
participants
August 10, 2006
Health
Canada approves Betaseron for treatment of first clinical
event suggestive
of MS
August
9, 2006
Study
suggests tetanus vaccination associated with lower risk of
developing MS
August
8, 2006
Place
of residence in childhood may influence development of MS
risk
July 27, 2006
Small study combines Novantrone and Copaxone as potential MS treatment
June 23, 2006
Small Edmonton-based
clinical trial shows some slowing of disease progression
June 2, 2006
FDA approves Tysabri's
return to market in USA for relapsing MS
May 2, 2006
MS experts estimate number
of Canadians with MS is 55,000 to 75,000
April 20, 2006
Reporting from the AAN:
Promising MS Clinical Trial Results
April 7, 2006
Recruitment of participants underway for combination
therapy study
April 7, 2006
Clinical trial for
oral Lipitor still enrolling participants for study
February-24-2006
Clinical trial underway
for new monoclonal antibody daclizumab
February-24-2006
Tysabri Update: FDA permits some clinical
trial participants to resume treatment
Jan-24-2006
BC researchers find disability progression in MS is slower
than previously reported
Jan-20-2006
Status of rituximab in multiple sclerosis
back
to top
2005
Multiple sclerosis research progress prominent at ECTRIMS – ACTRIMS joint
meeting September 28 – October 1, 2005
Nov-25-2005
Influenza vaccination
and multiple sclerosis
Oct-24-2005
Beta interferon therapy use during pregnancy linked to miscarriage and low
birth rate
Oct-17-2005
Study reports regional variation of MS rates across Canada
Sep-28-2005
Initial results reported of blood test that may predict active multiple sclerosis
Sep-23-2005
Campath clinical trial
for MS suspended after serious risks identified
Research
News from American Academy of Neurology Meeting, April 9
-16, 2005
Jul-29-2005
Clinical trial of Fampridine-SR
underway
Study sites in Canada and US open for enrolment
Jun-20-2005
Sativex® available
by prescription for treatment of MS-related pain
May-26-2005
MS
Society of Canada and MS Scientific Research Foundation announce
$2.25 million myelin repair project
Apr-19-2005
Health Canada approves
Sativex®for treatment of MS-related pain
Apr-11-2005
Tysabri Update:
Third case of progressive multifocal leukoencephalopathy
Feb-28-2005
Sales of Tysabri
stopped in United States
Feb-25-2005
Pilot study test
combination of n-acetylcysteine and Copaxone as potential
MS treatment
Feb-18-2005
Two-year results released
from Tysabri clinical trial
Feb-18-2005
Bone Marrow Transplantation
Study Update: Participants Treated in Study to Stop MS Progression
Back to top
2004
Jan-16-2004
Study Reports Possible Link Between Vitamin
D and Reduced MS Risk
Mar-19-2004
MS Society-funded Researchers
Identify Key Component in MS-like Disease
Mar-19-2004
MS Society-funded Researchers
Identify Key Component in MS-like Disease
May-7-2004
MS Scientific Research
Foundation Funded Study Looks at Canadian Children to Uncover
Triggers of Multiple Sclerosis
Jun-11-2004
Small Study of Minocycline
Shows Promise as MS Therapy
Jul-23-2004
Progressive MS
therapy clinical trial announced
Jul-23-2004
Bayer HealthCare
submits cannabis spray for Health Canada
Sep-07-2004
Biogen Idec and Elan
Pharmaceuticals announce Health Canada priority review for
Antegren®
Sep-16-2004
Small study suggests
MS development may be linked to hepatitis B vaccination
Oct-12-2004
University of Calgary
led study suggests ancient viral protein may be part of multiple
sclerosis development
Oct-27-2004
Influenza vaccination
and multiple sclerosis
Nov-10-2004
Biogen Idec and Elan
Pharmaceuticals release initial one-year results from Antegren
clinical trial
Dec-1-2004
Research
News from ECTRIMS - European Committee for Treatment and Research
in Multiple Sclerosis, October 6 - 9, 2004
Dec-1-2004
Research News from
ACTRIMS – Americas Committee for Treatment and Research
in Multiple Sclerosis, October 3, 2004
Dec-10-2004
FDA approves
natalizumab (Tysabri® - formerly known as
Antegren) for relapsing forms of MS
approval
Dec-21-2004
Initial enrollment
begins for clinical trial testing therapy for secondary-progressive
MS
Back to top
2003
Jan-2-2003
Antegren Clinical Trial Results Encouraging
as Potential MS Treatment
Mar-13-2003
MS Research Progress
Mar-14-2003
Long-Term Benefits of Interferons
in MS Subject of Journal Review Article
May-15-2003
Bone Marrow Transplant Study Update
Participant Death Appears Related
to Transplant Complications
Aug-20-2003
Study Examines Exposure to Sunlight
and Risk of Developing Multiple Sclerosis
Sept-17-2003
Health Canada Extends
Avonex Labelling to Include First Attack and Supporting MRI
Data
Oct-16-2003
Overview of provincial government coverage for MS disease modifying therapies only
Nov-21-2003
Study Reports Smoking As Risk Factor For
MS
Nov-24-2003
Results from Two Studies of Marijuana
and Multiple Sclerosis
Dec-16-2003
Health Canada Advisory
Letter Regarding Interferon Treatment
Back to top
2002
Nov-30-2002
Copaxone Study Halted in Primary-Progressive
MS
Oct-21-2002
Pregnancy hormone estriol Reduces
MS Lesions in Small Study
May-10-2002
Bone Marrow Transplantation Study
Update:First Participants Treated Seeks to Stop Multiple
Sclerosis Progress
Feb-27-2002
Angiotech Halts Study of Micellar
Paclitaxel stating no benefit of statistical significance
seen
Feb-7-2002
Results of Clinical Trial of Prokarin
(Procarin) To Treat Muliptle Sclerosis Fatigue
Oct-21-2002
Sexual Transmission Theory Not Based
on Established Data
Sep-9-2002
Montreal Study Examines Lifestyle,
Medical History Factors and MS
Back to top
2001
Antegren (natalizumab)
Results Look Promising in Small Study
Interdisciplinary
Study Targets MMPs in MS -- One of Just 10 Research Projects
Funded by CIHR
Jul-13-2001
Health Canada Clarifies
requirements Applying to Hyperbaric Oxygen Chambers and Notes
No Evidence Supporting Usefulness in MS
Toronto Researchers
Link Diabetes And Multiple Sclerosis And Probe Cows' Milk
Association
Oct-23-2001
New Foundation-funded
research: Multi-centre, Multi-disciplinary Study Seeks Ways
to Repair Myelin Damaged by MS
Back to top
2000
Back to top
1999
Oct-20-1999
Study of Betaseron
in Secondary-Progressive MS Stopped Early
MS Studies Released
at Medical Meeting Show Positive Benefits with Two Therapies
Viagra approved for
use in Canada
Highlights from the
American Academy of Neurology Meeting, April 1999
MS Society increases
research support by 60% during 50th Anniversary year
Back to top
1998
Herpes Virus HHV-6
in MS
Back to top
1997
Copaxone approved
in Canada for relapsing-remitting multiple sclerosis
Oct-17-1997
Information concerning
Ampligen®
Back to top
1996
Back
to top
|
